Results 31 to 40 of about 75,591 (303)

SnapShot: Neurobiology of opioid use disorder [PDF]

Cell, 2021
The use of opioid drugs and related overdose deaths, which rose to epidemic proportions over the past decade, have been exacerbated by the COVID pandemic, a time of great uncertainty and isolation. Much is known about opioid pharmacology and related neural circuits that, combined with novel emerging neurobiological insights, can help guide new ...
Randall J, Ellis, Tanni, Rahman, Jeremy, Sherman, Yasmin L, Hurd   +3 more
openaire   +2 more sources

Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study

Addiction Science & Clinical Practice, 2022
Background Medication for opioid use disorder (MOUD) reduces mortality, but few patients access MOUD. At a Federally Qualified Health Center (FQHC), we implemented a low barrier model of MOUD, including same-day MOUD initiation and a harm reduction ...
Jamie Carter, Zhen Li, Hillary Chen, Melissa Greiner, Christopher Bush, Debanjan Bhattacharya, Stephanie Poley, Nidhi Sachdeva, Jane Carolyn Crowder, Jacob Feigal   +9 more
doaj   +1 more source

Perspectives from Systems-Level Key Informants on Optimizing Opioid Use Disorder Treatment for Adolescents and Young Adults

Children
Background/Objectives: Rates of receiving opioid use disorder (OUD) treatment among adolescents and young adults (AYA) aged 16–25 are low. The current study qualitatively analyzed informants’ perspectives regarding the availability of, developmental ...
Jasper Yeh, Crosby Modrowski, Isabel Aguirre, Samantha Portis, Robert Miranda, Melissa Pielech   +5 more
doaj   +1 more source

A Systematic Review Examining Patient and Provider Attitudes Toward Use of Medication for Opioid Use Disorder [paper]

, 2023
Introduction: Despite drastically rising rates of opioid overdose related deaths, rigid opinions of both patients and providers against the use of medication for opioid use disorder persist in the face of well-established evidence indicating that ...
Trejo, Anyssa
core  

Acute Pain and Development of Opioid Use Disorder: Patient Risk Factors. [PDF]

, 2023
PURPOSE OF REVIEW Pharmacological therapy for acute pain carries the risk of opioid misuse, with opioid use disorder (OUD) reaching epidemic proportions worldwide in recent years.
Filipovic, Mark Georg, Bello, Corina, Urman, Richard D, Luedi, Markus M, Baumann, Livia, Andereggen, Lukas   +5 more
core   +1 more source

COVID‐19: A new barrier to treatment for opioid use disorder in the emergency department

Journal of the American College of Emergency Physicians Open, 2021
Objective Start Treatment and Recover (STAR) is an emergency department (ED) program that expands access to medication for opioid use disorder by identifying patients with opioid use disorder and offering ED‐initiated buprenorphine/naloxone and rapid ...
Warren Grunvald, Ramsey Herrington, Roz King, Miles Lamberson, Scott Mackey, Sanchit Maruti, Richard Rawson, Daniel Wolfson   +7 more
doaj   +1 more source

Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort

Drug and Alcohol Dependence Reports, 2023
Background: Research gaps exist on the use of medications for opioid use disorder (OUD) among birthing people. Methods: This retrospective cohort study included people who underwent childbirth deliveries during 2017-2020 and had a diagnosis of OUD ...
Xi Wang, Zachary Meisel, Katherine Kellom, Jennifer Whitaker, Douglas Strane, Anyun Chatterjee, Rebecka Rosenquist, Meredith Matone   +7 more
doaj   +1 more source

Comparative effectiveness of different treatment pathways for opioid use disorder.

, 2020
Question: What is the real-world effectiveness of different treatment pathways for opioid use disorder? Findings: In this comparative effectiveness research study of 40 885 adults with opioid use disorder that compared 6 different treatment pathways,
Wakeman, Sarah, Chaisson, Christine, Ameli, Omid, Crown, William H, McPheeters, Jeffrey Thomas, Azocar, Francisca, Sanghavi, Darshak M, Larochelle, Marc R   +7 more
core   +1 more source

Opioid use disorder awareness [PDF]

, 2023
This project based off of objectives from Healthy People 2030 addressed awareness related to opioid use disorder (OUD) in the form of history of opioid epidemic, pathophysiology of opioid addiction, signs and symptoms of abuse and physiologic effects of ...
Carey, Yela
core  

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV

Drug and Alcohol Dependence Reports, 2023
Background: In the United States, a disproportionate number of persons with HIV (PWH) and opioid use disorder (OUD) are involved in the justice system. Medications for OUD (MOUD) can reduce convictions and incarceration time in persons with OUD. Extended-
Kaley Parchinski, Angela Di Paola, Allison P. Wilson, Sandra A. Springer   +3 more
doaj   +1 more source